| Loss of the N-myc oncogene in a patient with a small interstitial deletion of the short arm of chromosome 2. | None |
| Comparison of transformation by manganese sulfate and 5-azacytidine in Rat 6 cells overexpressing the c-myc oncogene. | None |
| Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. | None |
| Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. | None |
| Transfection of cardiac muscle: effects of overexpression of c-myc and c-fos proto-oncogene proteins in primary cultures of neonatal rat cardiac myocytes. | None |
| Differential regulation of the N-myc proto-oncogene by ROR alpha and RVR, two orphan members of the superfamily of nuclear hormone receptors. | None |
| Calcium-dependent c-myc proto-oncogene expression and proliferation of Caco-2 cells: a role for a luminal extracellular calcium-sensing receptor. | None |
| Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression. | None |
| c-myc proto-oncogene expression by germinal center B cells isolated from human tonsils. | None |
| Overload-induced C-Myc oncoprotein is reduced in aged skeletal muscle. | None |
| Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia. | None |
| Transcription effect of nm23-M2/NDP kinase on c-myc oncogene. | None |
| Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. | None |
| Decreased expression of c-myc oncoprotein by peripheral blood mononuclear cells in thalassaemia patients receiving desferrioxamine. | None |
| Inhibition of cell growth in CaCO2 cells by the polyamine analogue N1,N12-bis(ethyl)spermine is preceded by a reduction in MYC oncoprotein levels. | None |
| [N-myc oncogene amplification in tumors of the sympathetic nervous system: preliminary study of methods and clinico-pathologic correlations]. | None |
| [Expression of transforming growth factor-alpha and myc oncoprotein in the human ovary during follicular growth, atresia and corpus luteum formation regression]. | None |
| Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. | None |
| Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway. | None |
| TNF alpha-induced aerobic synthesis of ATP on plasma membranes of target cells. The relation to the expression of the nuclear oncogene c-myc. | None |